VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $12,000 | +50.0% | 500 | -28.6% | 0.00% | +50.0% |
Q1 2017 | $8,000 | -20.0% | 700 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $10,000 | -41.2% | 700 | 0.0% | 0.00% | -40.0% |
Q3 2016 | $17,000 | +6.2% | 700 | -9.7% | 0.01% | 0.0% |
Q2 2016 | $16,000 | -20.0% | 775 | 0.0% | 0.01% | -37.5% |
Q1 2016 | $20,000 | -33.3% | 775 | +158.3% | 0.01% | -27.3% |
Q4 2015 | $30,000 | +66.7% | 300 | +200.0% | 0.01% | +57.1% |
Q3 2015 | $18,000 | -18.2% | 100 | 0.0% | 0.01% | -12.5% |
Q2 2015 | $22,000 | -45.0% | 100 | -50.0% | 0.01% | -42.9% |
Q1 2015 | $40,000 | +185.7% | 200 | +100.0% | 0.01% | +180.0% |
Q4 2014 | $14,000 | +7.7% | 100 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $13,000 | – | 100 | – | 0.01% | – |
Q2 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q1 2014 | $13,000 | +8.3% | 100 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $12,000 | +20.0% | 100 | 0.0% | 0.01% | +25.0% |
Q3 2013 | $10,000 | +11.1% | 100 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $9,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |